Free Trial
NASDAQ:PNTG

The Pennant Group (PNTG) Stock Price, News & Analysis

$23.65
-0.17 (-0.71%)
(As of 10:57 AM ET)
Today's Range
$23.51
$23.76
50-Day Range
$19.63
$23.95
52-Week Range
$10.31
$24.09
Volume
10,518 shs
Average Volume
154,983 shs
Market Capitalization
$710.68 million
P/E Ratio
43.80
Dividend Yield
N/A
Price Target
$24.00

The Pennant Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
0.8% Upside
$24.00 Price Target
Short Interest
Healthy
1.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$7,516 Sold Last Quarter
Proj. Earnings Growth
17.81%
From $0.73 to $0.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.15 out of 5 stars

Medical Sector

560th out of 904 stocks

Health Services Industry

4th out of 10 stocks

PNTG stock logo

About The Pennant Group Stock (NASDAQ:PNTG)

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

PNTG Stock Price History

PNTG Stock News Headlines

Pennant Acquires South Texas Hospice Provider
RBC Capital Keeps Their Buy Rating on Pennant Group (PNTG)
Pennant Reports First Quarter 2024 Results
Pennant Acquires Senior Living Community in Idaho
The Pennant Group, Inc. (PNTG)
PNTG May 2024 17.500 put
See More Headlines
Receive PNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for The Pennant Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/06/2024
Today
6/06/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:PNTG
Fax
N/A
Employees
5,791
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.00
High Stock Price Target
$26.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+1.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$13.38 million
Pretax Margin
4.08%

Debt

Sales & Book Value

Annual Sales
$544.89 million
Cash Flow
$0.80 per share
Book Value
$4.86 per share

Miscellaneous

Free Float
28,303,000
Market Cap
$710.68 million
Optionable
Optionable
Beta
2.02
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Brent J. Guerisoli (Age 43)
    CEO & Director
    Comp: $1.37M
  • Mr. John J. Gochnour (Age 41)
    President & COO
    Comp: $1.13M
  • Ms. Lynette B. Walbom CPA (Age 46)
    Chief Financial Officer
    Comp: $763.44k
  • Mr. Kirk S. Cheney
    General Counsel & Corporate Secretary
  • Mr. Jason P. Steik
    Chief Clinical Officer
  • Mr. Brian W. Wayment
    President of Cornerstone Healthcare

PNTG Stock Analysis - Frequently Asked Questions

Should I buy or sell The Pennant Group stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Pennant Group in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PNTG shares.
View PNTG analyst ratings
or view top-rated stocks.

What is The Pennant Group's stock price target for 2024?

4 Wall Street research analysts have issued 1-year target prices for The Pennant Group's shares. Their PNTG share price targets range from $22.00 to $26.00. On average, they predict the company's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 0.8% from the stock's current price.
View analysts price targets for PNTG
or view top-rated stocks among Wall Street analysts.

How have PNTG shares performed in 2024?

The Pennant Group's stock was trading at $13.92 at the beginning of 2024. Since then, PNTG stock has increased by 71.1% and is now trading at $23.82.
View the best growth stocks for 2024 here
.

Are investors shorting The Pennant Group?

The Pennant Group saw a increase in short interest in May. As of May 15th, there was short interest totaling 311,100 shares, an increase of 18.3% from the April 30th total of 262,900 shares. Based on an average trading volume of 170,200 shares, the days-to-cover ratio is presently 1.8 days. Approximately 1.1% of the shares of the stock are short sold.
View The Pennant Group's Short Interest
.

When is The Pennant Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our PNTG earnings forecast
.

How were The Pennant Group's earnings last quarter?

The Pennant Group, Inc. (NASDAQ:PNTG) released its quarterly earnings results on Monday, May, 6th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.15. The business earned $156.92 million during the quarter, compared to analysts' expectations of $146.01 million. The Pennant Group had a trailing twelve-month return on equity of 13.42% and a net margin of 2.86%.

What ETFs hold The Pennant Group's stock?

ETFs with the largest weight of The Pennant Group (NASDAQ:PNTG) stock in their portfolio include Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).iShares U.S. Healthcare Providers ETF (IHF).

What other stocks do shareholders of The Pennant Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Pennant Group investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Energy Transfer (ET), Gilead Sciences (GILD), General Mills (GIS), Harley-Davidson (HOG), Helmerich & Payne (HP), International Business Machines (IBM), International Paper (IP) and Kohl's (KSS).

Who are The Pennant Group's major shareholders?

The Pennant Group's stock is owned by many different institutional and retail investors. Top institutional investors include 8 Knots Management LLC (8.19%), Vanguard Group Inc. (6.19%), Wasatch Advisors LP (4.21%), Riverbridge Partners LLC (4.13%), Crewe Advisors LLC (2.43%) and Kent Lake Capital LLC (1.83%). Insiders that own company stock include Barry M Smith, Brent Guerisoli, Christopher R Christensen, Daniel H Walker, Jennifer Freeman, Joanne Stringfield, John G Nackel and John J Gochnour.
View institutional ownership trends
.

How do I buy shares of The Pennant Group?

Shares of PNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PNTG) was last updated on 6/6/2024 by MarketBeat.com Staff

From Our Partners